How CSL’s new CEO stacks up against Brian McNamee and Paul Perreault
Less than a year into the job leading the blood products giant, Paul McKenzie is already under pressure to continue the company’s great Australian success story,
Patrick DurkinBOSS Deputy editor
If CSL’s new CEO, Paul McKenzie, is feeling the pressure over the company’s flagging share price, he is trying hard not to show it.
McKenzie is only the third CEO to lead the blood products giant since it was privatised by the Keating government in 1994. “I know, I know,” McKenzie shoots back in his distinctive US accent, almost before he is asked.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Leaders
Fetching latest articles